Keros Therapeutics Inc. (KROS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Keros Therapeutics Inc.

    NASDAQ: KROS · Real-Time Price · USD
    16.05
    0.25 (1.58%)
    At close: Sep 26, 2025, 3:59 PM
    15.76
    -1.81%
    After-hours: Sep 26, 2025, 05:32 PM EDT

    Keros Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 559.93M 331.15M 279.05M 230.04M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 1.45M 1.21M 1.33M 1.33M
    Other Long-Term Assets
    		 2.06M 2.05M 2.12M 82K
    Receivables
    		 4.46M 1.09M 841K 18M
    Inventory
    		 n/a n/a -841K 3.06M
    Other Current Assets
    		 1.48M 1M 180K 340K
    Total Current Assets
    		 588.89M 347.29M 285.77M 251.44M
    Property-Plant & Equipment
    		 23.49M 19.47M 17.57M 2.4M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 26.99M 22.73M 21.01M 3.81M
    Total Assets
    		 615.89M 370.02M 306.78M 255.25M
    Account Payables
    		 4.6M 5.45M 3.34M 3.65M
    Deferred Revenue
    		 n/a n/a n/a 7.13M
    Short-Term Debt
    		 n/a n/a 455K 862K
    Other Current Liabilities
    		 10.55M 10.38M 7.49M 3.99M
    Total Current Liabilities
    		 27.45M 24.37M 16.55M 11.85M
    Long-Term Debt
    		 n/a n/a 12.81M 231K
    Other Long-Term Liabilities
    		 n/a n/a -12.81M -231K
    Total Long-Term Liabilities
    		 16.88M 13.44M 12.81M 231K
    Total Liabilities
    		 44.33M 37.81M 29.36M 12.08M
    Total Debt
    		 18.86M 14.44M 13.27M 1.09M
    Book Value
    		 571.55M 332.21M 277.42M 243.17M
    Book Value Per Share
    		 15.27 11.28 10.99 10.42
    Common Stock
    		 4K 3K 2K 2K
    Retained Earnings
    		 -568.78M -381.43M -228.43M -123.75M
    Comprehensive Income
    		 n/a 0.00 -0.00 -0.00
    Shareholders Equity
    		 571.55M 332.21M 277.42M 243.17M
    Total Investments
    		 1.45M 1.21M 1.33M 1.33M

    Add to Watchlist